I can't answer to that, I hope someone else can, I'd like to know as well. My little glimmer of hope (deluded fool that I am) is that even after the final report, unless the IE "continues to conclude that the Revised Scheme is in the best interests of ResApp shareholders." the BOD is not required to support the revised Shemozzle of Acquiescence.
Ann: Cough detection patent granted in Australia and Japan, page-17
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
